Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
12
|
| pubmed:dateCreated |
1999-1-21
|
| pubmed:abstractText |
Osteopontin (OPN) is an Arg-Gly-Asp-containing phosphoprotein that is secreted by activated T cells. The concentration of serum OPN protein is elevated in autoimmune-prone MRL-lpr mice as well as in patients with systemic lupus erythematosus. Previously, it was shown that OPN induces the polyclonal activation of B cells, resulting in the augmented production of immunoglobulin, indicating that OPN plays some role in the development of autoimmune disease. However, the link between OPN and development of autoimmune disease remains unclear. To analyze the role of OPN in immune system and autoimmune diseases, we have generated two kinds of transgenic mice: one carries the immunoglobulin (Ig) enhancer/SV40 promoter and the other carries the cytomegalovirus enhancer/chicken beta-actin (CAG) promoter. In both groups of transgenic mice, the B1 cell population in peritoneal cavity was markedly increased and titer of IgM and IgG3 antibodies in the serum was considerably higher than that in wild-type mice. Most important, the titer of the IgM class of anti-double-stranded DNA antibody was significantly elevated in transgenic mice. These results strongly suggest that OPN may have an important role in the propagation and differentiation of B1 cells and production of autoantibodies.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Antinuclear,
http://linkedlifedata.com/resource/pubmed/chemical/Osteopontin,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/SPP1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Sialoglycoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Spp1 protein, mouse
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
Dec
|
| pubmed:issn |
0023-6837
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
78
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1523-33
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:9881952-Animals,
pubmed-meshheading:9881952-Antibodies, Antinuclear,
pubmed-meshheading:9881952-Antibody Formation,
pubmed-meshheading:9881952-B-Lymphocytes,
pubmed-meshheading:9881952-CD4-Positive T-Lymphocytes,
pubmed-meshheading:9881952-CD8-Positive T-Lymphocytes,
pubmed-meshheading:9881952-Flow Cytometry,
pubmed-meshheading:9881952-Humans,
pubmed-meshheading:9881952-Lupus Erythematosus, Systemic,
pubmed-meshheading:9881952-Lymphocyte Activation,
pubmed-meshheading:9881952-Mice,
pubmed-meshheading:9881952-Mice, Inbred MRL lpr,
pubmed-meshheading:9881952-Mice, Transgenic,
pubmed-meshheading:9881952-Osteopontin,
pubmed-meshheading:9881952-Peritoneal Cavity,
pubmed-meshheading:9881952-Phosphoproteins,
pubmed-meshheading:9881952-Sialoglycoproteins,
pubmed-meshheading:9881952-Spleen,
pubmed-meshheading:9881952-T-Lymphocytes,
pubmed-meshheading:9881952-Thymus Gland
|
| pubmed:year |
1998
|
| pubmed:articleTitle |
Introduction of an osteopontin gene confers the increase in B1 cell population and the production of anti-DNA autoantibodies.
|
| pubmed:affiliation |
Institute of Immunological Science, Hokkaido University, Sapporo, Japan.
|
| pubmed:publicationType |
Journal Article
|